Occlutech, with the slogan "Every beat counts.", was founded in 2003 and is headquartered in Sweden. The company operates in the Health Care and Manufacturing industries and is committed to providing the best treatment for serious heart conditions through the development and manufacture of minimally invasive cardiac devices. Since its inception, Occlutech has positively impacted thousands of patients and remains focused on continuously expanding its reach to improve more lives. In its latest funding round on 05 April 2023, Occlutech secured a notable €60.00M in debt financing investment from Ture Invest. This investment is indicative of the confidence that reputable investors have in the company's mission and potential for growth in the medical technology sector. With its dedication to making every heartbeat count, Occlutech is well-positioned to further its impact on patient outcomes and solidify its position as a leader in the cardiac care space.
No recent news or press coverage available for Occlutech.